BRCA2 and breast cancer: Further investigation of genetic alteration and loss of heterozygosity in BRCA1 and BRCA2 were conducted in feline triple negative, basal-like mammary adenocarcinomas to determine whether the presence of BRCA1/BRCA2 mutations was associated with this phenotype similar to the observations in human breast cancer.